Pay in 4 interest-free payments of $5.87 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Live in states not currently served: MadeMed does not currently serve patients in 10 states
This will be calculated at checkout if applicable
Label the vial with the fill volume, resulting concentration and reconstitution date
Hospital-backed health systems are expanding GLP-1 use to treat chronic kidney disease, cardiovascular complications, and non-alcoholic steatohepatitis (NASH), as per Morgan Stanley
de Saint-Hilaire ZM, M
Tirzepatide is a laboratory-designed peptide that researchers study to understand how simultaneously activating two important gut hormone pathways (GIP and GLP-1) affects blood sugar control, appetite, and metabolism in experimental settings
US$ 27.76
US$ 27.58
US$ 23.86
US$ 28.26
